Butterfly Network, Inc.
BFLYHealthcareNASDAQMedical Devices · Last scanned May 29, 2026
Scan Results
Daily timeframe1 of 4 indicators bullish as of May 28
Part of the healthcare sector, Butterfly Network, Inc. (BFLY) is listed under Medical Devices. Valued at $1.21B, BFLY is a small-cap name in its sector. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market.
Market Cap
$1.21B
Beta
2.28
P/E (TTM)
—
P/E (Fwd)
-49.84
EPS (TTM)
$-0.30
EPS (Fwd)
$-0.09
ROE
-35.2%
ROA
-11.2%
Cash
$138.0M
Total Debt
$19.8M
Free CF
$8.9M
52W Change
92.1%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $138.0M in cash comfortably exceeding the $19.8M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $8.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -35.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $62.6M (2021) to $97.6M (2025), reflecting a 56% increase over the period.
Butterfly Network, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. With cash comfortably exceeding debt, BFLY has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Butterfly Network, Inc.'s trajectory.